From: The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma
Variables | Odds ratio | 95% confidence interval | P-value |
---|---|---|---|
Gender - Female | 1.076 | 0.531 to 2.182 | 0.838 |
Age | 0.999 | 0.980 to1.019 | 0.933 |
AFP ≥ 1000 | 1.935 | 1.179 to 3.176 | 0.009 |
PIVKA-II ≥ 200 | 1.136 | 0.677 to 1.906 | 0.630 |
White blood cells | 0.933 | 0.813 to 1.071 | 0.325 |
Hemoglobin | 0.884 | 0.782 to 1.001 | 0.051 |
Platelet count | 1.002 | 1.000 to 1.004 | 0.075 |
INR | 2.822 | 0.154 to 51.533 | 0.484 |
Albumin | 0.443 | 0.231 to 0.850 | 0.014 |
Total bilirubin | 1.162 | 0.570 to 2.367 | 0.680 |
AST | 1.002 | 0.998 to 1.006 | 0.313 |
ALT | 1.000 | 0.996 to 1.004 | 0.919 |
ALP > 80 IU/mL | 2.216 | 1.282 to 3.830 | 0.004 |
Glucose | 0.998 | 0.993 to 1.004 | 0.998 |
Creatinine | 0.787 | 0.368 to 1.683 | 0.537 |
Type of operation (non-anatomical) | 1.402 | 0.711 to 2.768 | 0.330 |
Maximum tumor size | 0.990 | 0.990 to 1.008 | 0.780 |
Cirrhosis | 1.690 | 0.926 to 3.084 | 0.087 |
Grade (3 and 4) | 1.141 | 0.612 to 2.130 | 0.678 |
Capsular invasion | 0.532 | 0.277 to 1.020 | 0.057 |
Microvascular invasion | 1.812 | 0.566 to 5.797 | 0.317 |
Portal vein invasion | 1.642 | 0.933 to 2.889 | 0.085 |
Bile duct invasion | 1.184 | 0.371 to 3.785 | 0.775 |
Serosa involvement | 1.142 | 0.457 to 2.851 | 0.776 |
Intrahepatic metastasis | 2.019 | 1.265 to 3.517 | 0.004 |
Multicentric occurrence | 0.481 | 0.118 to 1.966 | 0.308 |